Intervention Review

Histamine type 2 receptor antagonists as adjuvant treatment for resected colorectal cancer

  1. Sanjeev Deva1,*,
  2. Michael Jameson2

Editorial Group: Cochrane Colorectal Cancer Group

Published Online: 15 AUG 2012

Assessed as up-to-date: 16 DEC 2011

DOI: 10.1002/14651858.CD007814.pub2


How to Cite

Deva S, Jameson M. Histamine type 2 receptor antagonists as adjuvant treatment for resected colorectal cancer. Cochrane Database of Systematic Reviews 2012, Issue 8. Art. No.: CD007814. DOI: 10.1002/14651858.CD007814.pub2.

Author Information

  1. 1

    Auckland Hospital, Cancer and Blood, Auckland, New Zealand

  2. 2

    Waikato Hospital, Oncology Department, Hamilton, Waikato, New Zealand

*Sanjeev Deva, Cancer and Blood, Auckland Hospital, Park Road, Grafton, Auckland, New Zealand. sanjeev.deva@gmail.com. sanjeevd@adhb.govt.nz.

Publication History

  1. Publication Status: New
  2. Published Online: 15 AUG 2012

SEARCH

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens

or

Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.